...
首页> 外文期刊>Clinical and vaccine immunology: CVI >Generation and Characterization of Chimeric Antibodies against NS3, NS4, NS5, and Core Antigens of Hepatitis C Virus
【24h】

Generation and Characterization of Chimeric Antibodies against NS3, NS4, NS5, and Core Antigens of Hepatitis C Virus

机译:抗丙型肝炎病毒NS3,NS4,NS5和核心抗原的嵌合抗体的产生和表征

获取原文

摘要

Mouse-human chimeric antibodies (cAbs) against hepatitis C virus (HCV) core, NS3 (nonstructural), NS4, and NS5 antigens were developed as quality control (QC) reagents to replace the use of human sera/plasma for Abbott HCV immunoassays. The cAb retains the mouse monoclonal antibody (MAb) specificity and affinity but still reacts in the existing HCV assay format, which measures human anti-HCV immunoglobulin. Mouse heavy-chain (VH) and light-chain (VL) variable regions of anti-HCV core, NS3, NS4, and NS5 antigens were PCR amplified from hybridoma lines and then cloned with human IgG1 heavy-chain (CH) and light-chain (CL) constant regions, respectively. A single mammalian expression plasmid containing both heavy-chain and light-chain immunoglobulin genes was constructed and transfected into dihydrofolate reductase (DHFR)-deficient Chinese hamster ovary (CHO) cells. The transfected CHO cells were selected using hypoxanthine- and thymidine-free medium and screened by an enzyme immunoassay (EIA). The clone secreting the highest level of antibody was isolated from the CHO transfectants and further subcloned. Each cAb-expressing CHO cell line was weaned into serum-free medium, and the cAb was purified by protein A affinity chromatography. The levels of cAb production for the various CHO cell lines varied from 10 to 20 mg/liter. Purified anti-HCV cAbs were tested with Abbott HCV immunoassays and showed reactivity. Moreover, yeast surface display combined with alanine-scanning mutagenesis was used to map the epitope at the individual amino acid level. Our results suggest that these HCV cAbs are ideal controls, calibrators, and/or QC reagents for HCV assay standardization.
机译:针对丙型肝炎病毒(HCV)核心,NS3(非结构性),NS4和NS5抗原的小鼠人嵌合抗体(cAb)已开发为质量控制(QC)试剂,以取代人类血清/血浆用于雅培HCV免疫测定。 cAb保留了小鼠单克隆抗体(MAb)的特异性和亲和力,但仍以现有的HCV检测形式反应,该检测形式可检测人的抗HCV免疫球蛋白。从杂交瘤中PCR扩增抗HCV核心,NS3,NS4和NS5抗原的小鼠重链(V H )和轻链(V L )可变区系,然后分别克隆人IgG1重链(C H )和轻链(C L )恒定区。构建了包含重链和轻链免疫球蛋白基因的单个哺乳动物表达质粒,并将其转染到缺乏二氢叶酸还原酶(DHFR)的中国仓鼠卵巢(CHO)细胞中。使用无次黄嘌呤和无胸腺嘧啶核苷的培养基选择转染的CHO细胞,并通过酶免疫测定法(EIA)进行筛选。从CHO转染子中分离出分泌最高水平抗体的克隆并进一步亚克隆。将每种表达cAb的CHO细胞系断奶至无血清培养基中,并通过蛋白A亲和层析纯化cAb。各种CHO细胞系的cAb产生水平从10到20 mg / L不等。纯化的抗HCV cAb用Abbott HCV免疫测定法进行了测试,并显示出反应活性。此外,酵母表面展示与丙氨酸扫描诱变相结合被用于在单个氨基酸水平上定位表位。我们的结果表明,这些HCV cAb是用于HCV分析标准化的理想对照,校准物和/或QC试剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号